Merger creates $5 billion pharma technology company

Norstella and Citeline (formerly Pharma Intelligence) have merged to form a $5 billion global company, one of the largest pharma intelligence solutions providers on the market.

Norstella now has more than 1,500 employees across its five brands: Evaluate, MMIT, Panalgo, The Dedham Group, and Citeline.

“We believe that patient access starts with identifying unmet needs and doesn’t end until a patient has a therapy in hand,” commented Mike Gallup, CEO of Norstella.

Our AI capabilities are built to evolve—transforming data into insight, insight into action, and action into impact.